OTC:VRBCF Virbac (VRBCF) Stock Price, News & Analysis $346.00 0.00 (0.00%) As of 06/20/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesSEC FilingsBuy This Stock About Virbac Stock (OTC:VRBCF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Virbac alerts:Sign Up Key Stats Today's Range$346.00▼$346.0050-Day Range$324.00▼$346.0052-Week Range$324.00▼$383.52VolumeN/AAverage Volume100 shsMarket CapitalizationN/AP/E Ratio52.32Dividend Yield0.55%Price TargetN/AConsensus RatingN/A Company OverviewVirbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.Read More… Receive VRBCF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virbac and its competitors with MarketBeat's FREE daily newsletter. Email Address VRBCF Stock News HeadlinesVIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effective September 1, 2025June 19 at 2:30 AM | globenewswire.comVirbac : Declaration of the number of shares and voting rights 04/2025May 7, 2025 | finance.yahoo.com379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving lives in aviation — it’s solving the biggest flaw in AI. And only one U.S. company has the patent.June 22, 2025 | True Market Insiders (Ad)Virbac : Public release of Virbac Annual Report at 31 December 2024April 28, 2025 | globenewswire.comVirbac SA (0NM7) Gets a Hold from Kepler CapitalApril 18, 2025 | markets.businessinsider.comVirbac: In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scopeApril 15, 2025 | globenewswire.comPet Dental Health Market Forecast Report 2025-2030, with Petdentist, Virbac, Animal Dental Clinic, iM3, The Happy Jack Co., Pet Kare Clinic, Felican Pet Hospital, Ruddington Vets, Pets'n'Vets and moreApril 14, 2025 | globenewswire.comVirbac : Declaration of the number of shares and voting rights 03/2025April 10, 2025 | finance.yahoo.comSee More Headlines VRBCF Stock Analysis - Frequently Asked Questions How have VRBCF shares performed this year? Virbac's stock was trading at $339.23 on January 1st, 2025. Since then, VRBCF stock has increased by 2.0% and is now trading at $346.00. View the best growth stocks for 2025 here. How do I buy shares of Virbac? Shares of VRBCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTC SectorMedical Industry Drug Manufacturers - General Sub-IndustryN/A Current SymbolOTC:VRBCF CIK2029969 Webwww.virbac.fr Phone33.4.92.08.71.00FaxN/AEmployees5,459Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio52.32 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (OTC:VRBCF) was last updated on 6/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virbac SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Virbac With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
